Is taysha gene therapies a buy?
Taysha Gene Therapies's analyst rating consensus is a 'Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
Is TSHA a good buy?
Out of 8 analysts, 5 (62.5%) are recommending TSHA as a Strong Buy, 3 (37.5%) are recommending TSHA as a Buy, 0 (0%) are recommending TSHA as a Hold, 0 (0%) are recommending TSHA as a Sell, and 0 (0%) are recommending TSHA as a Strong Sell.
Should I buy or sell Taysha Gene Therapies stock right now?
11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Taysha Gene Therapies in the last year. There are currently 11 b...
What is Taysha Gene Therapies' stock price forecast for 2022?
11 brokerages have issued 1 year target prices for Taysha Gene Therapies' stock. Their forecasts range from $16.00 to $44.00. On average, they anti...
How has Taysha Gene Therapies' stock price performed in 2022?
Taysha Gene Therapies' stock was trading at $11.65 at the beginning of 2022. Since then, TSHA stock has decreased by 69.3% and is now trading at $3...
When is Taysha Gene Therapies' next earnings date?
Taysha Gene Therapies is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for...
How were Taysha Gene Therapies' earnings last quarter?
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) announced its earnings results on Monday, May, 16th. The company reported ($1.31) earnings per share for...
Who are Taysha Gene Therapies' key executives?
Taysha Gene Therapies' management team includes the following people: Mr. R. A. Session II , Founder, Pres, CEO & Director (Age 43, Pay $634.63k...
Who are some of Taysha Gene Therapies' key competitors?
Some companies that are related to Taysha Gene Therapies include Caribou Biosciences (CRBU) , Atara Biotherapeutics (ATRA) , Ocugen (OCGN) , Im...
When did Taysha Gene Therapies IPO?
(TSHA) raised $125 million in an IPO on Thursday, September 24th 2020. The company issued 6,600,000 shares at a price of $18.00-$20.00 per share. G...
What is Taysha Gene Therapies' stock symbol?
Taysha Gene Therapies trades on the NASDAQ under the ticker symbol "TSHA."
About Taysha Gene Therapies
Taysha Gene Therapies (NASDAQ:TSHA) Frequently Asked Questions
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.
Recently Viewed Tickers
11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Taysha Gene Therapies in the last twelve months. There are currently 11 buy ratings for the stock.
Taysha Gene Therapies Inc
Visit a quote page and your recently viewed tickers will be displayed here.